Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Patent
1998-02-19
2000-03-07
Moezie, Minna
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
A61K 3128
Patent
active
060341254
ABSTRACT:
The method of this invention is directed to a treatment of depression in men and women by administering to a patient a therapeutically effective amount of chromium in a pharmaceutically acceptable form. Chromium, preferably in the form of chromium picolinate, is administered to the patient at dosages in a preferred range of about 200 to about 500 micrograms chromium.
REFERENCES:
patent: 5196351 (1993-03-01), Harris et al.
patent: 5422281 (1995-06-01), Harris et al.
patent: 5470846 (1995-11-01), Sandyk
Sue Miller, "A Natural Mood Booster", Newsweek, (May 5, 1997), 74-75.
Stone et al., "Fluoxetine in the Treatment of Premenstrual Syndrome", Psycho. Pharmacology Bulletin, vol. 26, No. 3, (1990), pp. 331-335.
Steiner et al., "Fluoxetine in the Treatment of Premenstrual Dysphoria", New England Journal of Medicine, vol. 332, No. 23, (Jun. 8, 1995), pp. 1529-1535.
Yonkers et al., "Symptomatic Improvement of Premenstrual Dysphoric Disorder with Sertraline Treatment", JAMA, vol. 278, No. 12, (Sep. 24, 1997), pp. 983-988.
McCarty, M.F., Medical Hypotheses, vol. 43, pp. 247-252, 1994.
LandOfFree
Method of treating depression using chromium does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating depression using chromium, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating depression using chromium will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363676